Phialogics
Phialogics is a next-gen IgV therapeutics developer founded in 2021.
1
Funding Rounds
$660.0k
Money raised
Overview
Phialogics is a next-gen IgV therapeutics developer founded in 2021.
- Website:
- Headquarters: Basel
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Phialogics has raised a total of $660k in funding over 1 rounds.
Key Insights:
- Phialogics April 2023 Pre-Seed Funding Round: $660k
Phialogics April 2023 Pre-Seed Funding Round
$660k